PROVISION OF VITAMIN D IN PATIENTS WITH CHRONIC HEPATITIS C
DOI:
https://doi.org/10.11603/1681-2727.2019.3.10630Keywords:
chronic hepatitis C, vitamin DAbstract
The aim of the work – to analyze the level of vitamin D (25 hydroxycalciferol (25(OH)D) in patients with chronic hepatitis C (HCV) prior to the start of antiviral therapy.
Materials and methods. 100 people who are registered as patients with chronic viral hepatitis in the Dnipropetrovsk region, whose serum was determined by the liver metabolite of vitamin D, 25 hydroxycalciferol (25(OH)D), which is currently indicates the available amount of vitamin D in the human body. Patients were divided according to the level of vitamin D into 3 groups (patients with normal levels, insufficiency and vitamin D deficiency). Evaluation of vitamin D-status was performed according to the classification (M.F. Holick, 2011), according to which the level of 25(OH)D in serum from 75–200 nmol/l or 30–85 ng/ml corresponds to the norm, the level of 25-hydroxycalciferol from 75 nmol/l to 50 nmol/l or 29–20 ng/ml in the blood is considered to be as insufficiency of vitamin D and an indicator lower than 50 nmol/l or less than 20 ng/ml corresponds to a vitamin D deficiency.
Results and discussion. The study showed that only 18 (18.0 %) patients had sufficient vitamin D levels, 38 patients (38.0 %) had vitamin D insufficiency, and most patients 44 (44.0 %) were diagnosed with vitamin D deficiency, indicating the apparent relationship between vitamin D levels and chronic hepatitis C. Vitamin D deficiency was found to be prevalent in the age groups of 45–59 years (61.4 %) and 25–44 years (22.7 %). It was determined that vitamin D level among HCV patients did not depend on gender.
References
Anastasіi І.A. (2007). Svitovyi dosvis terapii khvorykh na khronichnyi hepatyt [World experience in therapy of patients with chronic hepatitis C]. Іnfektsіinі khvoroby – Infectious Diseases, 3, 102-103 [in Ukrainian].
Bueverov, A. (2008). Khronicheskiy gepatit C i sochetannaya patologiya pecheni [Chronic hepatitis C and concomitant liver disease]. Klinicheskie perspektivy gastroenterologii i gepatologii – Clinical Prospects of Gastroenterology and Hepatology, 6, 9-15 [in Russian].
Global Hepatitis Report (2017). Electronic resource, Geneva. Retrieved from: http://www.who.int/hepatitis/ publications/global-hepatitis-report2017/en
Ramagopalan, S.V., Heger, A., Berlanga, J., Narelle, J.M., Matthew, R.L., Amy, B., … Julian, C.K. (2010). A ChIP-seq-defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Research, 10, 1352-1360. DOI: https://doi.org/10.1101/gr.107920.110
Gao, L., Tao, Y., & Zhang, L. (2010). Vitamin D receptor genetic polymorphisms and tuberculosis: an updated systematic review and meta-analysis. Int. J. Tuberc. Lung Dis., 1, 15-23.
Villar, L.M., Del Campo, J.A., & Ranchal, I. (2013). Association between vitamin D and hepatitis C virus infection: a meta-analysis. World J. Gastroenterol., 35, 5917-5924. DOI: https://doi.org/10.3748/wjg.v19.i35.5917
Yamshchikov, A.V., Desai, N., Blumberg, H. (2009). Vitamin D for the treatment and prevention of infectious diseases: an asystematic review of randomized controlled trials. Endocr. Pract., 5, 438-449. DOI: https://doi.org/10.4158/EP09101.ORR
Rode, A., Fourlanos, S., & Nicoll, A. (2010). Oral vitamin D replacement is effective in chronic liver disease. Clin. Biol. Gastroenterol., 34, 618-620. DOI: https://doi.org/10.1016/j.gcb.2010.07.009
Takuya, M., Takanobu, K., Nao, S., Megumi, T., Asako, M., Takahiro, M., … Michio, I. (2012). 25-hydroxyvitamin D3 suppresses hepatitis C virus production. J. Hepatol., 56, 1231-1239. DOI: https://doi.org/10.1002/hep.25763
Arteh, J., Narra, S., & Nair, S. (2010) Prevalence of vitamin D deficiency in chronic liver disease. Dig. Dis. Sci., 55, 2624-2628.
Stokes, C.S., Krawczyk, M., Reichel, C., Lammert, F., & Grungah, F. (2014). Vitamin D deficiency is associated with mortality in patients withadvanced liver cirrhosis. Eur. J. Clin. Invest., 44, 176-183. DOI: https://doi.org/10.1111/eci.12205
Pang, Q., Qu, K., Zhang, J.Y., Liu, C. (2015). Evidence supporting a beneficial role of vitamin D in chronic hepatitis C. Journal of Hepatology, Retrieved from: http: // dx. doi.org/10.1016/j.jhep.2015.03.037.
Norman, A.W. (2008). From vitamin D to hormones D [Fundamentals of vitamin D endocrine system essential for good health. Am. J. Clin. Nutr., 88 (2), 491-499. DOI: https://doi.org/10.1093/ajcn/88.2.491S
Holick, M.F., Binkley, N.C., Bischoff-Ferrari, H.A., Gordon, C.M., Hanley, D.A, Heaney, R.P., Murad, M.H., & Weaver, C.M. (2011). Evaluation, treatment, and prevention of vitamin D deficiency. An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab., 96 (7), 1911-1930.
Downloads
Published
How to Cite
Issue
Section
License
Journal Infectious Disease (Infektsiini Khvoroby) allows the author(s) to hold the copyright without registration
Users can use, reuse and build upon the material published in the journal but only for non-commercial purposes
This journal is available through Creative Commons (CC) License BY-NC "Attribution-NonCommercial" 4.0
